Quick Takeaways
- Ayrton Capital LLC filed SCHEDULE 13G/A for 180 Life Sciences Corp. Common Stock, par value $0.0001 per share (ATNF).
- Disclosed ownership: 4.6%.
- Date of event: 31 Mar 2025.
Ayrton Capital LLC - 31 Mar 2025 SCHEDULE 13G/A Report for 180 Life Sciences Corp. Common Stock, par value $0.0001 per share (ATNF)
- Filing Manager
- Ayrton Capital LLC
- Reporting Manager
- Ayrton Capital LLC
- Symbol
- ATNF
- Shares outstanding
- 5,430,879 shares
- Disclosed Ownership
- 247,105 shares
- Ownership
- 4.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2025, 15:02:39 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ayrton Capital LLC disclosed 4.6% ownership in 180 Life Sciences Corp. Common Stock, par value $0.0001 per share (ATNF) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 15:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 4.6% | 247,105 | 247,105 | 0 | /s/ Waqas Khatri | Waqas Khatri / Managing Member | |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 4.6% | 247,105 | 247,105 | 0 | /s/ Waqas Khatri | Waqas Khatri / Director | |
| Waqas Khatri | 4.6% | 247,105 | 247,105 | 0 | /s/ Waqas Khatri | Waqas Khatri |